A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, Phd; Karen A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Coinfection and Other Clinical Characteristics of COVID-19 In
Coinfection and Other Clinical Characteristics of COVID-19 in Children Qin Wu, MD,a,p Yuhan Xing, MD,b,p Lei Shi, MB,a,p Wenjie Li, MS,a Yang Gao, MS,a Silin Pan, PhD, MD,a Ying Wang, MS,c Wendi Wang, MS,a Quansheng Xing, PhD, MDa BACKGROUND AND OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is abstract a newly identified pathogen that mainly spreads by droplets. Most published studies have been focused on adult patients with coronavirus disease 2019 (COVID-19), but data concerning pediatric patients are limited. In this study, we aimed to determine epidemiological characteristics and clinical features of pediatric patients with COVID-19. METHODS: We reviewed and analyzed data on pediatric patients with laboratory-confirmed COVID-19, including basic information, epidemiological history, clinical manifestations, laboratory and radiologic findings, treatment, outcome, and follow-up results. RESULTS: A total of 74 pediatric patients with COVID-19 were included in this study. Of the 68 case patients whose epidemiological data were complete, 65 (65 of 68; 95.59%) were household contacts of adults. Cough (32.43%) and fever (27.03%) were the predominant symptoms of 44 (59.46%) symptomatic patients at onset of the illness. Abnormalities in leukocyte count were found in 23 (31.08%) children, and 10 (13.51%) children presented with abnormal lymphocyte count. Of the 34 (45.95%) patients who had nucleic acid testing results for common respiratory pathogens, 19 (51.35%) showed coinfection with other pathogens other than SARS-CoV-2. Ten (13.51%) children had real-time reverse transcription polymerase chain reaction analysis for fecal specimens, and 8 of them showed prolonged existence of SARS-CoV-2 RNA. -
CONNECTION the Official Newsletter of Zhejiang University Issue 16 Feb.2020
CONNECTION The Official Newsletter of Zhejiang University Issue 16 Feb.2020 COVID-19 Special Issue Stand Strong Message from Editor-in-Chief CONNECTION Welcome to the special COVID-19 issue of Issue 16 CONNECTION, which highlights the efforts and contributions of ZJU community in face of the epidemic. As a group, they are heroes in harm's way, givers and doers who respond swiftly to the need of our city, our country and the world. When you read their stories, you'll recognize the strength and solidarity that define all ZJUers. ZJU community has demonstrated its courage and resilience in the battle against the novel coronavirus. At this time, let us all come together to protect ourselves and our loved ones, keep all those who are at the front lines in our prayers and pass on our gratitude to those who have joined and contributed to the fight against the virus. Together, we will weather this crisis. LI Min, Editor-in-Chief Director, Office of Global Engagement Editorial office : Global Communications Office of Global Engagement, Zhejiang University 866 Yuhangtang Road, Hangzhou, P.R. China 310058 Phone: +86 571 88981259 Fax: +86 571 87951315 Email: [email protected] Edited by : CHEN Weiying, AI Ni Designed by : HUANG Zhaoyi Material from Connection may be reproduced accompanied with appropriate acknowledgement. CONTENTS Faculty One of the heroes in harm’s way: LI Lanjuan 03 ZJU medics answered the call from Wuhan 04 Insights from ZJU experts 05 Alumni Fund for Prevention and Control of Viral Infectious Diseases set up 10 Alumni community mobilized in the battle against COVID-19 11 Education Classes start online during the epidemic 15 What ZJUers feel about online learning 15 Efforts to address concerns, avoid misinformation 17 International World standing with us 18 International students lending a hand against the epidemic 20 What our fans say 21 FacultyFaculty ZJU community has taken on the responsibility to join the concertedZJU community efforts has takenagainst on thethe responsibility spreadto join the of concerted the virus. -
Dokumentation Des COVID-19-Ausbruchs: Zeitleiste
Dokumentation des COVID-19-Ausbruchs: Zeitleiste JOURNALISMUS MEIN BERICHT https://web.archive.org/web/20210611015902/https://www.jenniferzengblog.com/home/2021/6/1 0/documentary-of-covid-19-outbreak-timeline (Anmerkung von Jennifer: Dieses Dokument enthält hauptsächlich chinesische Nachrichtenberichte über COVID-19, die zu Beginn des Ausbruchs (vom 1. Dezember bis 31. Januar) veröffentlicht wurden. Einige davon wurden von chinesischen Nachrichtenmedien und lokalen chinesischen Regierungen veröffentlicht Hinweise auf die mögliche Absicht der chinesischen Regierung, die Epidemie zum Schweigen zu bringen und zu vertuschen. Viele Artikel wurden später aus dem Internet gelöscht, aber eine Gruppe von Interessierten hat sie auf GitHub gespeichert. Sie organisieren die Archive in einer Zeitleiste mit dem Zweck, "zu bewahren". Geschichte, damit die Wahrheit im Laufe der Zeit nicht verborgen oder vergessen wird. Die ursprüngliche Zeitleiste ist auf Chinesisch. Dies ist eine englische Übersetzung, damit westliche Leser auch die Wahrheit hinter dem Covid-19-Ausbruch erfahren können. Dies ist ein übersetztes Dokument. Das Originaldokument ist in (Chinesisch): https://web.archive.org/web/20200419085730/https://github.com/Pratitya /COVID-19-timeline/blob/master/TIMELINE.md 1. Dezember 2019 · Der erste Einwohner von Wuhan hatte Symptome einer ungeklärten Lungenentzündung (nach der Diagnose war es zu diesem Zeitpunkt eine unbekannte Lungenentzündung mit unbekannter Ursache und kein Arzt gefunden und gemeldet). Laut Wu Wenxuan, Direktor der Intensivstation (ICU) des Jinyintan Krankenhauses, war der Patient ein Mann in den 70ern mit einem leichten Hirninfarkt und Alzheimer. Nachdem er krank wurde, wurde er in ein anderes Krankenhaus in Wuhan eingeliefert, aber als sich sein Zustand verschlechterte, wurde er am 29. Dezember in das Jinyintan-Krankenhaus verlegt. -
How the Health Rumor Misleads People's Perception in A
International Journal of Environmental Research and Public Health Article How the Health Rumor Misleads People’s Perception in a Public Health Emergency: Lessons from a Purchase Craze during the COVID-19 Outbreak in China Liwei Zhang 1, Kelin Chen 2 , He Jiang 3 and Ji Zhao 4,* 1 School of Public Administration, Jilin University, Changchun 130012, China; [email protected] 2 Institute of Urban Governance, Shenzhen University, Shenzhen 518060, China; [email protected] 3 Department of Social Psychology, Nankai University, Tianjin 300350, China; [email protected] 4 School of International and Public Affairs, Shanghai Jiao Tong University, Shanghai 200030, China * Correspondence: [email protected]; Tel.: +86-186-8676-2106 Received: 21 August 2020; Accepted: 29 September 2020; Published: 2 October 2020 Abstract: Health rumors often mislead people and cause adverse health behaviors. Especially during a public health emergency, health rumors may result in severe consequences for people’s health and risk governance. Insight into how these rumors form and harm people’s health behavior is critical for assisting people in establishing scientific health cognition and to enhance public health emergency responses. Using the case study with interview data of a salient purchase craze led by a health rumor during the COVID-19 outbreak in China, this article aimed to illustrate the process of how a piece of information becomes a health rumor. Furthermore, we identify factors that cause people to believe rumors and conduct behavior that leads to a purchase craze. Results show that a public misunderstanding of the unique psychology of uncertainty, cultural and social cognition, and conformity behavior jointly informs people’s beliefs in rumors and further causes purchase craze behavior. -
Coronavirus Brief
CAIXIN GLOBAL INTELLIGENCE CORONAVIRUS BRIEF Feb. 07 Executive Summary The Novel Coronavirus (2019-nCov) outbreak has severely disrupted the Chinese economy since mid-January this year. Economists broadly agree that the shock should be temporary but will drag down economic growth for 2020. Caixin Global Intelligence (CGI) has compiled a brief covering the current status, timeline of events, and overview of economists’ expected potential impacts and responses. 1 2 Timeline Dec.08 First infection after virus breaks species barrier in Wuhan Wuhan health commission acknowledges "mysterious pneumonia" and alerts hospitals, in a Dec.30 memo later leaked to the public National Health Commission sends team of experts to Wuhan, led by prominent epidemiologist Dec.31 and pulmonologist Zhong Nanshan Huanan Seafood Wholesale Market closed; Wuhan police punishes eight doctors for "spreading Jan.01 rumors" about virus 41 patients in Wuhan confirmed to have contracted the virus, including 27 with direct exposure Jan.02 to the Huanan Seafood Wholesale Market Jan.07 Pathogen of unexplained viral pneumonia identified as a Novel Coronavirus Jan.09 First death Jan.10 Virus genome sequenced Jan.13 First confirmed case outside of China Jan.19 China confirms first cases outside of Wuhan Zhong Nanshan reveals person-to-person transmission; Premier Li Keqiang urges decisive Jan.20 efforts to control the epidemic Zhong Nanshan reveals person-to-person transmission; Premier Li Keqiang urges decisive Jan.20 efforts to control the epidemic Officials announce quarantine of Wuhan effective the next day; North Korea closes its border, Jan.22 the first country to do so; WHO holds first emergency meeting to determine if virus constitutes a "public health emergency of international concern" (PHEIC) First confirmed incidence of human transmission outside China; almost all cities in Hubei Jan.24 enforce quarantine Jan.25 U.S. -
Lessons from Dermatology About Inflammatory Responses in Covid‐19
Received: 2 May 2020 Revised: 14 May 2020 Accepted: 15 May 2020 DOI: 10.1002/rmv.2130 REVIEW Lessons from dermatology about inflammatory responses in Covid-19 Paulo Ricardo Criado1,2 | Carla Pagliari3 | Francisca Regina Oliveira Carneiro4 | Juarez Antonio Simões Quaresma4 1Dermatology Department, Centro Universitário Saúde ABC, Santo André, Brazil 2Dermatology Department, Faculdade de Medicina, Centro Universitário Saúde ABC, Santo André, Brazil 3Pathology Department, Faculdade de Medicina, Universidade de S~ao Paulo, S~ao Paulo, Brazil 4Center of Biological and Health Sciences, State University of Pará, Belém, Brazil Correspondence Professor Paulo Ricardo Criado MD, PhD, Summary Dermatology Department, Centro The SARS-Cov-2 is a single-stranded RNA virus composed of 16 non-structural pro- Universitário Saúde ABC, Rua Carneiro Leao~ 33 Vila Scarpelli, Santo André, SP 09050-430, teins (NSP 1-16) with specific roles in the replication of coronaviruses. NSP3 has the Brazil. property to block host innate immune response and to promote cytokine expression. Email: [email protected] NSP5 can inhibit interferon (IFN) signalling and NSP16 prevents MAD5 recognition, depressing the innate immunity. Dendritic cells, monocytes, and macrophages are the first cell lineage against viruses' infections. The IFN type I is the danger signal for the human body during this clinical setting. Protective immune responses to viral infec- tion are initiated by innate immune sensors that survey extracellular and intracellular space for foreign nucleic acids. In Covid-19 the pathogenesis is not yet fully under- stood, but viral and host factors seem to play a key role. Important points in severe Covid-19 are characterized by an upregulated innate immune response, hypercoagulopathy state, pulmonary tissue damage, neurological and/or gastrointes- tinal tract involvement, and fatal outcome in severe cases of macrophage activation syndrome, which produce a ‘cytokine storm’. -
1. Sars-Cov Nucleocapsid Protein Epitopes and Uses Thereof
www.engineeringvillage.com Citation results: 500 Downloaded: 4/24/2020 1. SARS-COV NUCLEOCAPSID PROTEIN EPITOPES AND USES THEREOF KELVIN, David; PERSAD, Desmond; CAMERON, Cheryl; BRAY, Kurtis, R.; LOFARO, Lori, R.; JOHNSON, Camille; SEKALY, Rafick-Pierre; YOUNES, Souheil-Antoine; CHONG, Pele Assignee: UNIVERSITY HEALTH NETWORK; BECKMAN COULTER, INC.; UNIVERSITE DE MONTREAL; NATIONAL HEALTH RESEARCH INSTITUTES Publication Number: WO2005103259 Publication date: 11/03/2005 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 2. SARS-CoV-specific B-cell epitope and applications thereof Wu, Han-Chung; Liu, I-Ju; Chiu, Chien-Yu Assignee: National Taiwan University Publication Number: US20060062804 Publication date: 03/23/2006 Kind: Utility Patent Application Database: US Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 3. A RECOMBINANT SARS-COV VACCINE COMPRISING ATTENUATED VACCINIA VIRUS CARRIERS QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Assignee: INSTITUTE OF LABORATORY ANIMAL SCIENCE OF CHINESE ACADEMY OF MEDICAL SCIENCES; THE AARON DIAMOND AIDS RESEARCH CENTER; QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Publication Number: WO2006079290 Publication date: 08/03/2006 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data -
Lopinavir/Ritonavir for COVID-19: a Living Systematic Review Doi: 10.5867/Medwave.2020.06.7966
Lopinavir/ritonavir for COVID-19: A living systematic review doi: 10.5867/medwave.2020.06.7966 Appendix 3: Included, excluded and ongoing studies - Lopinavir/ritonavir for COVID-19: A living systematic review Included randomised trials LOTUS China (1,2) Details or comments REFERENCES Publication thread for LOTUS China Epistemonikos Chen et al (1) Type: Journal article Epistemonikos | DOI ChiCTR2000029387 (2) Type:Trial registry (Chinese Clinical Trial Registry) Epistemonikos | DOI (not available) STUDY DESIGN QUOTE: ☑Randomised trial Single centre , open-label, individually randomized, controlled trial; ☐Comparative, non- randomised Eligible patients were randomly assigned in a 1:1 ratio; ☐Non-comparative study To balance the distribution of oxygen support between the two groups as an indicator of severity of respiratory failure, randomization was stratified on the basis of respiratory support methods at the time of enrollment: no oxygen support or oxygen support with nasal duct or mask, or high-flow oxygen, noninvasive ventilation, or invasive ventilation including ECMO. The permuted block (four patients per block) randomization sequence, including stratification, was prepared by a statistician not involved in the trial, using SAS software, version 9.4 (SAS Institute). POPULATION: INCLUSION QUOTE: CRITERIA Patients were assessed for eligibility on the basis of a positive reverse-transcriptase– ☐COVID-19 polymerase-chain-reaction (RT-PCR) assay) for SARS-CoV-2 in a respiratory tract ☑COVID-19 pneumonia sample Male and nonpregnant female patients 18 years of age or older were eligible if they had a diagnostic specimen that was positive on RT-PCR, had pneumonia ☐Severe COVID-19 pneumonia confirmed by chest imaging, had an oxygen saturation of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen to the fraction 1 / 27 Lopinavir/ritonavir for COVID-19: A living systematic review doi: 10.5867/medwave.2020.06.7966 of inspired oxygen at or below 300 mg Hg. -
Looking Forward: Dr
Issue 4 2020 Executive insights, interviews, and intelligence for business in China P08 LinkedIn and the Future of Work P14 IMF on China’s Economic Prospects P32 Jim McGregor on Bilateral Frictions Looking Forward: Dr. Zhang Wenhong on COVID-19 and the Future of China's Public Health System www.amchamchina.org An exclusive, premium service for AmCham China members who require in-depth policy insights and privileged access to policy- makers. ExclusiveExclusive Benefits Benefits Meeting INSIGHT Special Report INSIGHT Policy Briefs INSIGHT Special Reports INSIGHT Highlights In-depth analysis of major policy issues and market trends (4-8 pages) Timely analysisinsights of and new analysis policies, from regulations, Policy+ and In-depth analysis of major policy issues amendmentsexclusive events (1-3 and pages) government meetings and market trends (4-6 pages) ¿(1-3 Recent pages) Developments in Capital Controls ¿ Recent Developments in Capital Controls RoundtablesRoundtable ACCESSACCESS ExecutiveExclusive Dialogues ACCESS ACCESS As a Policy+ subscriber, you receive priority Briefings and Meetings Discussion between member companies and Discussions between member companies invites to our meetings with government In addition to 200+ events hosted by governmentofficials from officials both the on topicsUS and of China.interest and think tanks, associations, and other non- ¿ Government Dialogue on Central Economic governmentAmCham China stakeholders each year, you will be invited to exclusive breakfasts, luncheons, Work Conference ¿ Conversation -
Fast Track to Recovery: US-China Collaboration on COVID-19 Prevention and Treatment
Fast Track to Recovery: US-China Collaboration on COVID-19 Prevention and Treatment Participant Biographies John R. Allen, President, The Brookings Institution John Rutherford Allen assumed the presidency of the Brookings Institution in November 2017 after having served as chair of security and strategy and a distinguished fellow at Brookings. Allen is a retired U.S. Marine Corps four-star general and former commander of the NATO International Security Assistance Force (ISAF) and U.S. Forces in Afghanistan. After retiring from the Marine Corps, he served as senior advisor to the secretary of defense on Middle East Security, during which he led the security dialogue for the Israeli/Palestinian peace process, and then as special presidential envoy to the Global Coalition to Counter ISIL. Qiu Yong, President, Tsinghua University Qiu Yong has been president of Tsinghua University since 2015 and a member of the Chinese Academy of Sciences since 2013. He is currently a member of the Standing Committee of the 13th National People’s Congress, vice chairman of the Education, Science, Culture and Public Health Committee of the 13th National People’s Congress, and deputy to the 13th National People's Congress. Professor Qiu’s research interests primarily focus on organic electronics, optoelectronics, semiconductors, and organic light emitting materials and devices. He has been devoted to both fundamental research on Organic Light Emitting Diodes (OLED) and technology transfer. Professor Qiu enrolled at Tsinghua University in 1983, where he received both his B.A. (1988) and Ph.D. (1994) in chemistry. He joined the Tsinghua University faculty in the Department of Chemistry in 1994. -
The Wuhan Coronavirus and Its Impact on China's Foreign Relations
12 2 April 2020 The Wuhan Coronavirus and Its Impact on China’s Foreign Relations – Part One Lindsay Hughes Senior Research Analyst Indo-Pacific Research Programme Key Points China has semi-officially denied that the coronavirus that is currently sweeping across the world originated there. Beijing has also claimed that it is a role model in its handling of the pandemic. Those claims are vigorously disputed by Western countries. The West is also becoming increasingly exasperated with China’s lies, double standards and apparent willingness to steal, blackmail and coerce. The West is now re-evaluating its individual and collective relationships with China. Summary The Covid-19 pandemic, which has swept through many parts of the world, had infected over 330,000 people globally at the time of writing and caused around 15,000 deaths by 23 March. In Australia, the number of confirmed cases has moved past 1,700, with 37 per cent of those being reported between 21 March and 23 March. This graph below shows the infection rate in Australia. In the US, the number of confirmed Covid-19 cases had surpassed 32,000 by 23 March, having grown ten-fold from a week earlier. New Zealand moved to the highest state of alert and closed its schools on 25 March, while India declared a “people’s curfew” on 22 March, leading to virtually empty streets in the capital, New Delhi, and in its financial capital, Mumbai. While most Indians complied with the curfew, many did not, leading the government there to declare that those who violated the curfew would face up to six months imprisonment. -
A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, Phd; Karen A
BRIEF REPORT Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January–February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, PhD; Karen A. Grépin, PhD; Hai Liang, PhD; Isaac Chun-Hai Fung, PhD ABSTRACT Objective: Awareness and attentiveness have implications for the acceptance and adoption of disease prevention and control measures. Social media posts provide a record of the public’s attention to an outbreak. To measure the attention of Chinese netizens to coronavirus disease 2019 (COVID-19), a pre-established nationally representative cohort of Weibo users was searched for COVID-19-related key words in their posts. Methods: COVID-19-related posts (N = 1101) were retrieved from a longitudinal cohort of 52 268 randomly sampled Weibo accounts (December 31, 2019–February 12, 2020). Results: Attention to COVID-19 was limited prior to China openly acknowledging human-to-human transmis- sion on January 20. Following this date, attention quickly increased and has remained high over time. Particularly high levels of social media traffic appeared around when Wuhan was first placed in quarantine (January 23–24, 8–9% of the overall posts), when a scandal associated with the Red Cross Society of China occurred (February 1, 8%), and, following the death of Dr Li Wenliang (February 6–7, 11%), one of the whis- tleblowers who was reprimanded by the Chinese police in early January for discussing this outbreak online. Conclusion: Limited early warnings represent missed opportunities to engage citizens earlier in the out- break. Governments should more proactively communicate early warnings to the public in a transparent manner.